The collaboration intends to pursue the most relevant human disease biology in a therapeutic modality-agnostic approach to develop first-in-class therapeutics for patients suffering from CKD.Evotec SE today announced its financial results for the first half-year of 2020: Significant Group revenue growth of 12% to € 231.0 m (H1 2019: € 207.1 m); Revenue growth in both business segments: EVT Execute revenues up 16% to € 228.2 m (H1 2019: € 196.8 m); EVT Innovate revenues up 8% to € 44.6 m (H1 2019: € 41.2 m); Adjusted Group EBITDA amounting to € 47.3 m (H1 2019: € 58.2 m)Evotec SE announced today that the Company has entered into a new partnership with the Biotech company Resolute Therapeutics (“Resolute”) to combat infectious diseases and antimicrobial resistance. Der Wert Evotec gehört mit einer positiven Entwicklung von 1,2 Prozent zu den Bestplatzierten des Tages. However, it is estimated that 10% of women worldwide are affected. An einem Standort im österreichischen Orth an der Donau werde mit der Evotec Gene Therapy ein neues Team von Gentherapie-Experten von Evotec ansässig sein, kündigt das Hamburger Biotech-Unternehmen am Montag an. The funding round led by new investor Novo Holdings raised $ 60 m with the existing investors’ consortium consisting of Evotec, Bristol Myers Squibb, and GT Healthcare Capital also participating in the round.Evotec SE today announced the financial results and corporate updates for the first quarter 2020. Under the terms of the agreement, Evotec and leon will cooperate on selected development programmes and maximise the effectiveness of clinical and commercial nanomedicines.Just – Evotec Biologics announced today that the Company has compiled a library of a new class of humanoid antibodies using a novel, AI-derived approach.
Zugleich melden die Norddeutschen den Abschluss einer mehrjährigen Zusammenarbeit im Bereich der Gentherapien von Evotec Gene Therapy mit dem japanischen Takeda-Konzern. The 9th edition of DDup is dedicated to our unique and innovative iPSC-based drug discovery programme TargetOur iPSC-based TargetRD DDup is here - https://t.co/arN1wi0ByL | This edition of DDup is dedicated to their unique… https://t.co/wnh3Mjwzqo The regimens will be designed to have little to no drug resistance and an acceptable safety profile, and be better-tolerated, shorter in duration and simpler to use than existing options. Furthermore, the Management Board will present an outlook for the fiscal year 2020.Evotec SE today announced that its Seattle-based subsidiary Just – Evotec Biologics, Inc. has entered into a partnership with Ology Bioservices, Inc. (“Ology Bio”) for the evaluation and analytical characterisation of antibodies against SARS-CoV-2.Evotec SE announced today that it will regain global development and commercialisation rights to the iPSC-based programme for the treatment of diabetes developed under collaboration agreement with Sanofi. We have taken a number of steps to ensure the continued health and safety of our colleagues during this challenging time.Evotec SE today announced that the Company has participated in the Series C funding round of Exscientia, the world-leading Artificial Intelligence (“AI”)-driven drug discovery company.
Verzögerung Deutsche Börse: 15 Min., Nasdaq, NYSE: 20 Min.
Zugleich melden die Norddeutschen den Abschluss einer mehrjährigen Zusammenarbeit im Bereich der Gentherapien von Evotec Gene Therapy mit dem japanischen Takeda-Konzern. The 9th edition of DDup is dedicated to our unique and innovative iPSC-based drug discovery programme TargetOur iPSC-based TargetRD DDup is here - https://t.co/arN1wi0ByL | This edition of DDup is dedicated to their unique… https://t.co/wnh3Mjwzqo The regimens will be designed to have little to no drug resistance and an acceptable safety profile, and be better-tolerated, shorter in duration and simpler to use than existing options. Furthermore, the Management Board will present an outlook for the fiscal year 2020.Evotec SE today announced that its Seattle-based subsidiary Just – Evotec Biologics, Inc. has entered into a partnership with Ology Bioservices, Inc. (“Ology Bio”) for the evaluation and analytical characterisation of antibodies against SARS-CoV-2.Evotec SE announced today that it will regain global development and commercialisation rights to the iPSC-based programme for the treatment of diabetes developed under collaboration agreement with Sanofi. We have taken a number of steps to ensure the continued health and safety of our colleagues during this challenging time.Evotec SE today announced that the Company has participated in the Series C funding round of Exscientia, the world-leading Artificial Intelligence (“AI”)-driven drug discovery company.
Verzögerung Deutsche Börse: 15 Min., Nasdaq, NYSE: 20 Min.